- Home
- COOK vs RVNC Comparison
COOK vs RVNC Comparison
Compare COOK & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOK
- RVNC
- Stock Information
- Founded
- COOK 1985
- RVNC 1999
- Country
- COOK United States
- RVNC United States
- Employees
- COOK N/A
- RVNC N/A
- Industry
- COOK Wholesale Distributors
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- COOK Consumer Discretionary
- RVNC Health Care
- Exchange
- COOK Nasdaq
- RVNC Nasdaq
- Market Cap
- COOK 406.5M
- RVNC 421.7M
- IPO Year
- COOK 2021
- RVNC 2014
- Fundamental
- Price
- COOK $2.98
- RVNC $3.08
- Analyst Decision
- COOK Buy
- RVNC Hold
- Analyst Count
- COOK 6
- RVNC 9
- Target Price
- COOK $4.00
- RVNC $8.45
- AVG Volume (30 Days)
- COOK 164.1K
- RVNC 3.3M
- Earning Date
- COOK 11-06-2024
- RVNC 11-07-2024
- Dividend Yield
- COOK N/A
- RVNC N/A
- EPS Growth
- COOK N/A
- RVNC N/A
- EPS
- COOK N/A
- RVNC N/A
- Revenue
- COOK $598,914,000.00
- RVNC $256,945,000.00
- Revenue This Year
- COOK $1.02
- RVNC $11.28
- Revenue Next Year
- COOK $4.69
- RVNC $27.21
- P/E Ratio
- COOK N/A
- RVNC N/A
- Revenue Growth
- COOK 3.17
- RVNC 25.82
- 52 Week Low
- COOK $1.97
- RVNC $2.30
- 52 Week High
- COOK $3.97
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- COOK 41.52
- RVNC 32.88
- Support Level
- COOK $2.94
- RVNC $3.06
- Resistance Level
- COOK $3.31
- RVNC $3.11
- Average True Range (ATR)
- COOK 0.14
- RVNC 0.14
- MACD
- COOK -0.02
- RVNC -0.00
- Stochastic Oscillator
- COOK 8.16
- RVNC 5.60
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.